Search results
To Your Good Health: Jardiance prescription comes with too many urinary issues
The Marshall News Messenger· 2 days agoROACH: I am a 64-year-old male, and my A1C level has been averaging around 7.4% for a number of...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 16 hours agoSales from Mounjaro grew nearly eightfold to $2.21 billion, handily beating forecasts. Sales of...
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 days agoAlso, continued higher demand and volume growth for Lilly’s key growth drugs (select products...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 20 hours agoThe stock has surged 52.5% in the past year. Eli Lilly: Its revenue growth is being driven by higher...
Dr. Roach: Eye drops safe to use with AMD medication
Detroit News· 16 hours agoDear Dr. Roach: I am a healthy 67-year-old female being treated with Eylea for wet age-related macular degeneration (AMD). Is it safe to use over-the-counter eye drops? Dear C.H.: Eylea is used ...
Eli Lilly and Company (NYSE:LLY) Shares Sold by Knights of Columbus Asset Advisors LLC
ETF DAILY NEWS· 4 days agoKnights of Columbus Asset Advisors LLC lessened its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 25.6% in the 4th quarter, according to the company in its most recent filing with ...
Eli Lilly and Company (NYSE:LLY) Trading 1.2% Higher
ETF DAILY NEWS· 1 day agoEli Lilly and Company (NYSE:LLY – Get Free Report)’s share price rose 1.2% during mid-day trading on Tuesday . The company traded as high as $741.20 and last traded at $739.90. Approximately ...
University of Iowa pharmacy counselor saves millions for patients
The Gazette· 5 days agoWhen Wendy Ostrem graduated from pharmacy school at the University of Iowa in 1986, pharmacies were...
Zacks Research Analysts Reduce Earnings Estimates for Eli Lilly and Company (NYSE:LLY)
ETF DAILY NEWS· 6 days agoEli Lilly and Company (NYSE:LLY – Free Report) – Equities research analysts at Zacks Research decreased their Q1 2026 earnings estimates for Eli Lilly and Company in a research note issued on ...